On Friday, Zymeworks BC Inc (NASDAQ: ZYME) opened lower -3.28% from the last session, before settling in for the closing price of $13.10. Price fluctuations for ZYME have ranged from $8.21 to $17.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 20.90% over the past five years. Company’s average yearly earnings per share was noted 2.56% at the time writing. With a float of $67.74 million, this company’s outstanding shares have now reached $69.58 million.
Let’s look at the performance matrix of the company that is accounted for 286 employees. In terms of profitability, gross margin is 90.49%, operating margin of -115.26%, and the pretax margin is -114.77%.
Zymeworks BC Inc (ZYME) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Zymeworks BC Inc is 3.58%, while institutional ownership is 101.93%. The most recent insider transaction that took place on May 15 ’25, was worth 565,847. In this transaction Director of this company bought 49,502 shares at a rate of $11.43, taking the stock ownership to the 17,877,989 shares. Before that another transaction happened on May 19 ’25, when Company’s Director bought 5,919 for $11.78, making the entire transaction worth $69,738. This insider now owns 17,883,908 shares in total.
Zymeworks BC Inc (ZYME) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 2.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.21% during the next five years compared to 15.81% growth over the previous five years of trading.
Zymeworks BC Inc (NASDAQ: ZYME) Trading Performance Indicators
Check out the current performance indicators for Zymeworks BC Inc (ZYME). In the past quarter, the stock posted a quick ratio of 4.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Zymeworks BC Inc (ZYME)
Zymeworks BC Inc (NASDAQ: ZYME) saw its 5-day average volume 0.54 million, a negative change from its year-to-date volume of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 74.49%. Additionally, its Average True Range was 0.64.
During the past 100 days, Zymeworks BC Inc’s (ZYME) raw stochastic average was set at 58.52%, which indicates a significant decrease from 68.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.07% in the past 14 days, which was lower than the 55.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.79, while its 200-day Moving Average is $13.09. Nevertheless, the first resistance level for the watch stands at $12.95 in the near term. At $13.22, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.53. If the price goes on to break the first support level at $12.36, it is likely to go to the next support level at $12.05. Assuming the price breaks the second support level, the third support level stands at $11.78.
Zymeworks BC Inc (NASDAQ: ZYME) Key Stats
There are currently 69,577K shares outstanding in the company with a market cap of 890.11 million. Presently, the company’s annual sales total 76,300 K according to its annual income of -122,700 K. Last quarter, the company’s sales amounted to 27,110 K and its income totaled -22,640 K.
